• December 5, 2019

    The newest addition to Tchaikapharma High Quality Medicines Inc. prescription drugs (Rx) product list are the following:

     

    – Zornichka (chlorthalidone) – for the treatment of arterial hypertension, essential or renovascular, or isolated systolic hypertension;

     

    – PlaquEx Combi (clopidogrel/acetylsalicylic acid) – for the secondary prevention of acute cardiovascular events;

     

    – Methylprednisolone -Tchaikapharma (methylprednisolone) – for the treatment of endocrine, rheumatic, collagenosis and immune-complex, skin, eye, gastrointestinal, respiratory,  hematological, oncology and edema diseases, as well as allergic conditions.

  • November 14, 2019

    Numerous spectators attended the traditional restoration of the Battle of Slivnitsa. Many volunteers were involved in the recreation of the events of the Serbo-Bulgarian War of 1885.

     

    slivnitsa-2019-1

     

    This year again, Tchaikapharma’s team took part in commemoration, as they traditionally participate in the recreation of historical events.

     

    Оn November 7, 2005, the company built and offered to the citizens a monument in memory of the killed Bulgarian officers, NCOs and soldiers on the occasion of the 120th anniversary of the victory in Slivnitsa of the Bulgarian army in the Serbian-Bulgarian war. The monument was inaugurated in the presence of the Vice President of the Republic of Bulgaria, Gen. Angel Marin, war veterans, representatives of military organizations and numerous citizens.

     

    slivnitsa-2019-2

     

    The recreation organizer is the national “Tradition” society – a voluntary, nongovernmental patriotic organization aimed at promoting and preserving patriotic traditions of military symbols and rituals, national values, weapons as a tribal memory, organizing and participating in recreating and events and battles of Bulgarian history.

     

    slivnitsa-2019-3

     

    After the historical recreation, the participants took a picture in front of the monument built by Tchaikapharma.

  • October 23, 2019

    Bulgaria’s Young Talents in The Field of Synthetic Biology Expressed Their Gratitude for The Support Provided

    mladi-talanti-biologia

    Tchaikapharma High Quality Medicines Ltd. supports Bulgaria’s Team of Synthetic Biology young specialists at their participation in the biggest bio engineering contest on the Planet – iGEM. The competition takes place in Boston, USA each year and accommodates more than 350 university teams from around the world. The Bulgarian team consists of future scientists and doctors from the Sofia University “Saint Kliment Ohridski”.

    Besides being a platform for young scientist development, iGEM is also looking to obtain solutions to socially viable challenges. The Bulgarian project is dedicated to a global issue – resistance of pathogenic microbes to antibiotics. Antimicrobial resistance is one of the main threats to human and animal health. It causes more than 33 000 deaths in the European Union each year and financial losses are over 1.5 billion Euro.

    The negative tendency for constant growth of the number of infections such as tuberculosis, pneumonia and others, which are caused by pathogenic microbes that are resistant to the currently applied medicines, define the antimicrobial resistance as a global issue with a significant relevance. According to the World Health Association and the European Commission, if no new treatments are found up to 2050, 10 million people will die every year due to infections, caused by multi-resistant bacteria.

    The team will travel at the end of the month and is currently preparing for the competition at the Sofia Tech Park labs.

     

  • Tchaikapharma High Quality Medicines ranks among the leaders in the Prescription Drugs (Rx) market for the past 12 months (as of June 2019).

     

    The ranking “Top 10 Corporations in the market for prescription products” of the world’s leading analytics company IQVIA  takes into account sales at end-customer prices, with Tchaikapharma increasing its market share is now ranked second by number of packages sold.

     

    The top ten Rx companies in Bulgaria hold 45% of the total market for prescription drugs.

  • September 18, 2018

    By the end of 2018, Tchaikapharma expects to be issued with Marketing Authorizations for three new prescription drugs, which will enrich the portfolio and the well-developed therapeutic baskets of the company with the following medications and indications:

     

    Chlorthidon (chlorthalidone) – for the treatment of arterial hypertension, essential or renovascular, or isolated systolic hypertension.

     

    PlaquEx Combi (clopidogrel/acetylsalicylic acid) – for the secondary prevention of acute cardiovascular events.

     

    Methylprednisolone-Tchaikapharma (methylprednisolone) – for the treatment of endocrine, rheumatic, collagenosis and immune-complex, skin, eye, gastrointestinal, respiratory,  hematological, oncology and edema diseases, as well as allergic conditions.

     

    Tchaikapharma International Press Center